Correlation Between RenovoRx and Cyclacel Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both RenovoRx and Cyclacel Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining RenovoRx and Cyclacel Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between RenovoRx and Cyclacel Pharmaceuticals, you can compare the effects of market volatilities on RenovoRx and Cyclacel Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in RenovoRx with a short position of Cyclacel Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of RenovoRx and Cyclacel Pharmaceuticals.
Diversification Opportunities for RenovoRx and Cyclacel Pharmaceuticals
-0.62 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between RenovoRx and Cyclacel is -0.62. Overlapping area represents the amount of risk that can be diversified away by holding RenovoRx and Cyclacel Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cyclacel Pharmaceuticals and RenovoRx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on RenovoRx are associated (or correlated) with Cyclacel Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cyclacel Pharmaceuticals has no effect on the direction of RenovoRx i.e., RenovoRx and Cyclacel Pharmaceuticals go up and down completely randomly.
Pair Corralation between RenovoRx and Cyclacel Pharmaceuticals
Given the investment horizon of 90 days RenovoRx is expected to generate 0.96 times more return on investment than Cyclacel Pharmaceuticals. However, RenovoRx is 1.04 times less risky than Cyclacel Pharmaceuticals. It trades about 0.02 of its potential returns per unit of risk. Cyclacel Pharmaceuticals is currently generating about -0.05 per unit of risk. If you would invest 210.00 in RenovoRx on September 4, 2024 and sell it today you would lose (90.00) from holding RenovoRx or give up 42.86% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 99.8% |
| Values | Daily Returns |
RenovoRx vs. Cyclacel Pharmaceuticals
Performance |
| Timeline |
| RenovoRx |
| Cyclacel Pharmaceuticals |
RenovoRx and Cyclacel Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with RenovoRx and Cyclacel Pharmaceuticals
The main advantage of trading using opposite RenovoRx and Cyclacel Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if RenovoRx position performs unexpectedly, Cyclacel Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cyclacel Pharmaceuticals will offset losses from the drop in Cyclacel Pharmaceuticals' long position.| RenovoRx vs. Candel Therapeutics | RenovoRx vs. Cingulate Warrants | RenovoRx vs. Unicycive Therapeutics | RenovoRx vs. Cardio Diagnostics Holdings |
| Cyclacel Pharmaceuticals vs. Eliem Therapeutics | Cyclacel Pharmaceuticals vs. Ikena Oncology | Cyclacel Pharmaceuticals vs. Ovid Therapeutics | Cyclacel Pharmaceuticals vs. Connect Biopharma Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |